Accelera Pharma Canada Inc. (“APCI”) is a Canadian based Importer and Distributor of both Prescription and Consumer Health products to wholesalers and retail customers across Canada.
We operate through two divisions - APCI (Rx) and APCI (Consumer Health).
Through our APCI (Rx) division we act as a proxy for international companies who plan to commercialise their products in Canada, without the need to out-licence or relinquish commercial control over their assets to a Canadian distributor.
At APCI (Rx) we also support continued product distribution in Canada following asset acquisitions/divestitures.
Through our APCI (Consumer Health) division we have commercial capabilities that focus on dermatology.
Our lead commercial line is Cliniderm®.
Company Details
- Employees
- 12
- Founded
- -
- Address
- 3330 Ridgeway Dr, Unit 12,canada
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://apcipharma.com/
- HQ
- Mississauga, Ontario
Accelera Pharma Questions
Accelera Pharma's website is https://apcipharma.com/
Accelera Pharma's LinkedIn profile is https://ca.linkedin.com/company/apcipharma
Accelera Pharma has
12 employees.
View email and phone details for 12
employees at Accelera Pharma.
Accelera Pharma's industry is
Pharmaceutical Manufacturing
Accelera Pharma's top competitors are
Amosey Inc.,
Bco Pharma,
Royal Pharma,
Adhererx,
Amherst Pharmasave,
Amp Guardian,
Medcare Medical Devices Canada,
Mocassins & Talons Hauts,
Bioscript Solutions,
Team Pharma.
Accelera Pharma's categories are Pharmaceutical Manufacturing
Accelera Pharma's founding year is 2018
